JPS51118773A - Quinolone alkane acid derivatives preparation method and pharmaceutical composite containing derivatives - Google Patents

Quinolone alkane acid derivatives preparation method and pharmaceutical composite containing derivatives

Info

Publication number
JPS51118773A
JPS51118773A JP51031184A JP3118476A JPS51118773A JP S51118773 A JPS51118773 A JP S51118773A JP 51031184 A JP51031184 A JP 51031184A JP 3118476 A JP3118476 A JP 3118476A JP S51118773 A JPS51118773 A JP S51118773A
Authority
JP
Japan
Prior art keywords
quinolone
composite containing
derivatives
alkane acid
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51031184A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0122267B2 (en:Method
Inventor
Robaato Buritein Debitsudo
Dagurasu Buraun Edowaado
Hetsupuwaasu Warutaa
Yosefu Suteishii Girubaato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB11644/75A external-priority patent/GB1502312A/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of JPS51118773A publication Critical patent/JPS51118773A/ja
Publication of JPH0122267B2 publication Critical patent/JPH0122267B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP51031184A 1975-03-20 1976-03-22 Quinolone alkane acid derivatives preparation method and pharmaceutical composite containing derivatives Granted JPS51118773A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11644/75A GB1502312A (en) 1975-03-20 1975-03-20 Quinolone derivatives
GB4204375 1975-10-14

Publications (2)

Publication Number Publication Date
JPS51118773A true JPS51118773A (en) 1976-10-18
JPH0122267B2 JPH0122267B2 (en:Method) 1989-04-25

Family

ID=26248416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51031184A Granted JPS51118773A (en) 1975-03-20 1976-03-22 Quinolone alkane acid derivatives preparation method and pharmaceutical composite containing derivatives

Country Status (19)

Country Link
US (1) US4066651A (en:Method)
JP (1) JPS51118773A (en:Method)
AU (1) AU1147676A (en:Method)
CS (1) CS188273B2 (en:Method)
DD (1) DD124117A5 (en:Method)
DE (1) DE2611824A1 (en:Method)
DK (1) DK115376A (en:Method)
ES (1) ES446234A1 (en:Method)
FI (1) FI760729A7 (en:Method)
FR (1) FR2304342A1 (en:Method)
HU (1) HU172032B (en:Method)
IE (1) IE43079B1 (en:Method)
IL (1) IL49126A0 (en:Method)
LU (1) LU74594A1 (en:Method)
NL (1) NL7602834A (en:Method)
NO (1) NO760993L (en:Method)
PT (1) PT64921B (en:Method)
SE (1) SE434394B (en:Method)
SU (1) SU648090A3 (en:Method)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03173870A (ja) * 1989-02-10 1991-07-29 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
WO1992021342A1 (en) * 1991-06-07 1992-12-10 Otsuka Pharmaceutical Co., Ltd. Antidiabetic
US5244898A (en) * 1991-04-19 1993-09-14 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5436254A (en) * 1989-02-10 1995-07-25 Otsuka Pharmaceutical Company, Ltd. Carbostyril derivatives

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
AU8665991A (en) * 1990-09-07 1992-03-30 Schering Corporation Antiviral compounds and antihypertensive compounds
DE19839499A1 (de) * 1998-08-29 2000-03-02 Merck Patent Gmbh 2-Oxo-2H-chinolinderivate
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
CA2378298A1 (en) 1999-08-27 2001-03-08 Lawrence G. Hamann 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators
CN1391576A (zh) 1999-08-27 2003-01-15 利甘德药品公司 雄激素受体调节剂化合物及方法
JP2003529545A (ja) 1999-09-14 2003-10-07 リガンド・ファーマシューティカルズ・インコーポレイテッド 改善された薬理学的プロファイルを有するｒｘｒモジュレーター
FR2811912B1 (fr) * 2000-07-21 2003-02-07 Gattefosse Ets Sa Procede d'enrobage de particules solides par un agent thermofusible, et particules solides ainsi enrobees
BRPI0413820A (pt) * 2003-08-22 2006-10-24 Ligand Pharm Inc derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
WO2009033702A1 (en) 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
ES2409215T3 (es) * 2007-09-14 2013-06-25 Janssen Pharmaceuticals, Inc. 4-fenil-1H-piridin-2-onas 1-3-disustituidas
CN101801951B (zh) 2007-09-14 2013-11-13 杨森制药有限公司 1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
WO2009062676A2 (en) * 2007-11-14 2009-05-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
WO2009062309A1 (en) * 2007-11-15 2009-05-22 Universite Laval Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof
EP2344470B1 (en) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
ES2466341T3 (es) 2008-10-16 2014-06-10 Janssen Pharmaceuticals, Inc. Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos
EP2373649B1 (en) 2008-11-28 2013-01-23 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
WO2010130424A1 (en) 2009-05-12 2010-11-18 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
BRPI1010831A2 (pt) 2009-05-12 2016-04-05 Addex Pharmaceuticals Sa derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2814998C (en) 2010-11-08 2019-10-29 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
CA2814996C (en) 2010-11-08 2019-10-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
DK3431106T3 (da) 2014-01-21 2021-03-15 Janssen Pharmaceutica Nv Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse
PT3096790T (pt) 2014-01-21 2019-10-15 Janssen Pharmaceutica Nv Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03173870A (ja) * 1989-02-10 1991-07-29 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
US5436254A (en) * 1989-02-10 1995-07-25 Otsuka Pharmaceutical Company, Ltd. Carbostyril derivatives
US5652247A (en) * 1989-02-10 1997-07-29 Otsuka Pharmaceutical Co., Ltd Carbostyril derivatives
US5244898A (en) * 1991-04-19 1993-09-14 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
WO1992021342A1 (en) * 1991-06-07 1992-12-10 Otsuka Pharmaceutical Co., Ltd. Antidiabetic

Also Published As

Publication number Publication date
LU74594A1 (en:Method) 1977-05-06
FI760729A7 (en:Method) 1976-09-21
ES446234A1 (es) 1977-10-01
JPH0122267B2 (en:Method) 1989-04-25
AU1147676A (en) 1977-09-01
CS188273B2 (en) 1979-02-28
US4066651A (en) 1978-01-03
FR2304342B1 (en:Method) 1979-09-21
IE43079L (en) 1976-09-20
PT64921A (en) 1976-04-01
SE434394B (sv) 1984-07-23
DD124117A5 (en:Method) 1977-02-02
FR2304342A1 (fr) 1976-10-15
SE7602339L (sv) 1976-09-21
IE43079B1 (en) 1980-12-17
IL49126A0 (en) 1976-05-31
DK115376A (da) 1976-09-21
DE2611824A1 (de) 1976-09-30
HU172032B (hu) 1978-05-28
NO760993L (en:Method) 1976-09-21
SU648090A3 (ru) 1979-02-15
DE2611824C2 (en:Method) 1987-06-19
NL7602834A (nl) 1976-09-22
PT64921B (en) 1977-08-24

Similar Documents

Publication Publication Date Title
JPS51118773A (en) Quinolone alkane acid derivatives preparation method and pharmaceutical composite containing derivatives
IL48990A (en) 687-benzomorphan derivatives methods for their preparation and pharmaceutical composition comprising them
IL49911A (en) 5-benzoyl-pyrrole-2-acetic acid derivatives, their preparation and pharmaceutical compositions containing them
JPS5268186A (en) Picolinic acid derivatives and their preparation
NZ180785A (en) Preparation of 5-aroyl-1-lower alkylpyr-rolf-2-acetic acid derivatives
IL50507A0 (en) Phenoxyalkylcarboxylic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL50657A (en) 11-deoxy-16-aryl- -tetranor-prosta-cis-5-ene-13-yneoic acid derivatives and their preparation
PH13924A (en) Glavulanic acid derivatives,pharmaceutical compositions containing same and method of preparation thereof
ZA767103B (en) Picolinic acid derivatives and processes for their preparation
JPS5212175A (en) Triazaspirodecanone derivatives and preparation method thereof
JPS5217478A (en) New homophthalimide derivatives and preparation method thereof
JPS5259161A (en) 1*44dihydroo2*66dimethyll44 phenyll3*55pyridineedicarbonic acid isobuthylmethyl preparation method and medicine thereof
JPS51141877A (en) New derivativives and salts of phenylpiperidine and preparation method and pharmaceutical composite
JPS51146476A (en) New preparation method of quinolinee33carbonic acid
PH13873A (en) Substituted thenoylacetic acid and esters,their pharmaceutical composition and method of use
GB1554310A (en) Process for the preparation of 5-oxo-hexanoic acid and derivatives thereof
JPS523070A (en) Pyridinetetracarboxylic acids and preparation method
PH14448A (en) P-dioxino(2,3-g)quinoline derivatives,their pharmaceutical preparation and method of using same
JPS5239678A (en) Chromene compound preparation method and uses thereof
JPS523060A (en) Paraachlorophenoxyisobutyric acid derivatives and preparation thereof
JPS51122008A (en) Dimercaptoethylether derivative preparation method and medicine containing same
JPS51115485A (en) Preparation method of quinoxalineedioxide derivatives
JPS523072A (en) Preparation method of 55alkyl picolinic acid
IL49449A0 (en) Bicyclic derivatives of 7-acylamido-3-cephem-4-carboxylic acid and process for their preparation
PH14245A (en) Derivatives of oxanilic acid,their pharmaceutical composition and method of use